The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide

European Journal of Neuroscience

Volumn 21, Issue 3, 2005, Pages 733-740

  Oba, Ryutaro ^a   Igarashi, Akira ^a   Kamata, Makiko ^a   Nagata, Kinya ^a   Takano, Syoichi ^a   Nakagawa, Hachiro ^b  

^a R and D Center   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Aggregation; Alzheimer's disease; Secretases

Indexed keywords

AMYLOID BETA PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME ACTIVE SITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; PC12 CELLS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RATS;

EID: 14944340658     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.03912.x     Document Type: Article

References (38)

1. Albrecht, D., Broser, M. & Kruger, H. (1997) Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats. Regul. Pept., 70, 105-109.
2. Caldwell, P.R., Seegal, B.C., Hsu, K.C., Das, M. & Soffer, R.L. (1976) Angiotensin-converting enzyme: vascular endothelial localization. Science, 191, 1050-1051.
3. Deddish, P.A., Wang, J., Michel, B., Morris, P.W., Davidson, N.O., Skidgel, R.A. & Erdos, E.G. (1994) Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc. Natl. Acad. Sci. USA, 91, 7807-7811.
4. Eckman, E.A., Watson, M., Marlow, L., Sambamurti, K. & Eckman, C.B. (2003) Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J. Biol. Chem., 278, 2081-2084.
5. Erdos, E.G. & Skidgel, R.A. (1987) The angiotensin I-converting enzyme. Laboratory Invest., 56, 345-348.
6. Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E.A., Frosch, M.P., Eckman, C.B., Tanzi, R.E., Selkoe, D.J. & Guenette, S. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl Acad. Sci. USA, 100, 4162-4167.
7. Georgians, D., Beau, F., Czarny, B., Cotton, J., Yiotakis, A. & Dive, V. (2003) Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Circ. Res., 93, 148-154.
8. Hardy, J. & Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353-356.
9. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. & Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J. Mol. Biol., 218, 149-163.
10. Hu, J., Igarashi, A., Kamata, M. & Nakagawa, H. (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta) retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J. Biol. Chem., 276, 47863-47868.
11. Iwata, N., Mizukami, H., Shirotani, K., Takaki, Y., Muramatsu, S., Lu, B., Gerard, N.P., Gerard, C., Ozawa, K. & Saido, T.C. (2004) Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. J. Neurosci., 24, 991-998.
12. Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N.P., Gerard, C., Hama, E., Lee, H.J. & Saido, T.C. (2001) Metabolic regulation of brain Abeta by neprilysin. Science, 292, 1550-1552.
13. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.J., Hama, E.. Sekine-Aizawa, Y. & Saido, T.C. (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med., 6, 143-150.
14. Jackson, B., Cubela, R. & Johnston, C. (1986) Angiotensin converting enzyme (ACE), characterization by 125I-MK351A binding studies of plasma and tissue ACE during variation of salt status in the rat. J. Hypertens., 4, 759-765.
15. Jaspard, E., Wei, L. & Alhenc-Gelas, F. (1993) Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kinase II). Studies with bradykinin and other natural peptides. J. Biol. Chem., 268, 9496-9503.
16. Kakinuma, Y., Hama, H., Sugiyama, F., Goto, K., Murakami, K. & Fukamizu, A. (1997) Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice. Neurosci. Lett., 232, 167-170.
17. Kakinuma, Y., Kama, H., Sugiyama, F., Yagami, K., Goto, K., Murakami, K. & Fukamizu, A. (1998) Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nat. Med., 4, 1078-1080.
18. Kasahara, Y. & Ashihara, Y. (1981) Colorimetry of angiotensin-I converting enzyme activity in serum. Clin. Chem., 27, 1922-1925.
19. Kehoe, P.G. (2003) The renin-angiotensin-aldosterone system and Alzheimer s disease? J. Renin Angiotensin Aldosterone Syst., 4, 80-93.
20. Kramar, E.A., Harding, J.W. & Wright, J.W. (1997) Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes. Regul. Pept., 68, 131-138.
21. Lanzillo, J.J., Stevens, J., Dasarathy, Y., Yotsumoto, H. & Fanburg, B.L. (1985) Angiotensin-converting enzyme from human tissues. Physicochemical, catalytic, and immunological properties. J. Biol. Chem., 260, 14938-14944.
22. Leissring, M.A., Farris, W., Chang, A.Y., Walsh, D.M., Wu, X., Sun, X., Frosch, M.P. & Selkoe, D.J. (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron, 40, 1087-1093.
23. LeVine, H. 3rd (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci., 2, 404-410.
24. Marr, R.A., Rockenstein, E., Mukherjee, A., Kindy, M.S., Hersh, L.B., Gage, F.H., Verma, I.M. & Masliah, E. (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci., 23, 1992-1996.
25. Nakai, K., Syoh, T. & Hiramori, K. (1995) Angiotensin-I converting enzyme. Nippon Rinsyo, 53, 1232-1236.
26. Reid, I.A. (1992) Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am. J. Physiol., 262, E763-E778.
27. Rousseau, A., Michaud, A., Chauvet, M.T., Lenfant, M. & Corvol, P. (1995) The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol Chem., 270, 3656-3661.
28. Selkoe, D.J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 81, 741-766.
29. Shearman, M.S., Ragan, C.I. & Iversen, L.L. (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA, 91, 1470-1474.
30. Skidgel, R.A. & Erdos, E.G. (1985) Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA, 82, 1025-1029.
31. Skoog, I., Wallin, A., Fredman, P., Hesse, C., Aevarsson, O., Karlsson, I., Gottfries, C.G. & Blennow, K. (1998) A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology, 50, 966-971.
32. Soubrier, F., Alhenc-Gelas, F., Hubert, C., Allegrini, J., John, M., Tregear, G. & Corvol, P. (1988) Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. USA, 85, 9386-9390.
33. Soubrier, F., Hubert, C., Testut, P., Nadaud, S., Alhenc-Gelas, F. & Corvol, P. (1993) Molecular biology of the angiotensin I converting enzyme. I. Biochemistry and structure of the gene. J. Hypertens., 11, 471-476.
34. Wei, L., Alhenc-Gelas, F., Soubrier, F., Michaud, A., Corvol, P. & Clauser, E. (1991a) Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J. Biol. Chem., 266, 5540-5546.
35. Wei, L., Alhenc-Gelas, F., Corvol, P. & Clauser, E. (1991b) The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem., 266, 9002-9008.
36. Wei, L., Clauser, E., Alhenc-Gelas, F. & Corvol, P. (1992) The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem., 267, 13398-13405.
37. Wright, J.W., Stubley, L., Pederson, E.S., Kramar, E.A., Hanesworth, J.M. & Harding, J. W. (1999) Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J. Neurosci., 19, 3952-3961.
38. Yang, H.Y., Erdos, E.G. & Levin, Y. (1970) A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim. Biophys. Acta, 214, 374-376.